Eurocine Vaccines discloses interim report for July – September 2021
Eurocine Vaccines AB hereby discloses the interim report for July – September 2021. Below is a summary of the report. The full report is available at Eurocine Vaccines’ website and as an attachment.2021-07-01– 2021-09-30 (first quarter) · Results after tax during the first quarter amounted to -4.0 MSEK (-3.2 MSEK) · Revenues during the first quarter amounted to 0 KSEK (158 KSEK) · Earnings per share the first quarter -0.3 SEK (-0.4 SEK)* *During the third quarter of the financial year 2020/2021, the Company carried out a merger of shares in